Oct 24, 2019
Hemanext Announces Publication of Data Demonstrating Significant Benefits Following the Transfusion of Hypoxically Stored Red Blood Cells
Oct 03, 2019
Hemanext to Present Extensive, Significant Red Blood Cell Data at AABB 2019
Sep 26, 2019
Emmaus Life Sciences Announces its Common Stock to Begin Trading on OTCQB September 26
Sep 19, 2019
Emmaus Life Sciences Announces Withdrawal of Marketing Authorization Application to European Medicines Agency
Aug 28, 2019
Emmaus Life Sciences Adds Oncology Supply as Distributor
Aug 14, 2019
Emmaus Life Sciences to Host "Sideline Sickle Cell" Community Town Hall with ASAP and FSCDR in South Florida
Jul 24, 2019
Emmaus Life Sciences Brings "Sideline Sickle Cell" Campaign to Dallas for Participation in Annual Warriors Convention
Jul 11, 2019
Lovelace Biomedical & Exemplar Genetics Win New Contract to Develop New Model of Sickle Cell Disease
Jul 03, 2019
Emmaus Life Sciences Announces Hiring Of New Endari® Product Manager
Jun 18, 2019
Emmaus Life Sciences' 'Sideline Sickle Cell' Campaign Teams Up with SCTPN for World Sickle Cell Day Event on June 19
Jun 10, 2019
PNH Treatment Market Size Worth $5.8 Billion by 2025 | CAGR: 11.2%: Grand View Research, Inc.
May 29, 2019
Emmaus Life Sciences Announces New CFO and EMA Opinion
May 13, 2019
California Leaders in Science and Policy Discuss Impacts of Sickle Cell Disease
Apr 25, 2019
The Worldwide Market for Anemia Treatment Drugs to 2026 - The Overall Competitive Scenario is Expected to Observe a Paradigm Shift Towards Gene Therapy & Monoclonal Antibody Therapies
Apr 15, 2019
NFL Broadcaster Solomon Wilcots and Emmaus Life Sciences Kick Off "Sideline Sickle Cell" Campaign during National Minority Health Month
Apr 09, 2019
Medunik USA expands access to Siklos® for pediatric sickle cell anemia patients by offering 340B pricing to covered entities through Apexus
Apr 02, 2019
Green Park Collaborative and Sickle Cell Disease Association of America, Inc. Launch coreSCD to Develop Consensus on Critical Outcomes in Sickle Cell Disease Clinical Research
Mar 18, 2019
Arix Bioscience plc: Arix Co-leads $63 Million Series B Investment Round for Imara
Mar 11, 2019
Endari Is a Proven Safe and Effective Sickle Cell Treatment
Feb 21, 2019
PharmaEssentia and AOP Orphan Receive EU Approval of Besremi(TM) (Ropeginterferon Alfa-2b) for Treatment of Polycythemia Vera (PV) in EU